Jefferies keeps SFBC at buy

SFBC International Inc. was maintained at a buy rating with a $27 price target by Jefferies & Co., Inc. analyst David Windley. The company is not out of the woods in the analyst's estimation. Jefferies believes that client attrition in Miami may have been slightly worse than its modeling but may have begun to improve. Management is forecasting $33 million to $35 million from the Miami facility in 2006. Shares of the Princeton, N.J., drug development services company were down 30 cents, or 1.29%, at $23.04 on volume of 278,303 shares versus the three-month running average of 1,120,820 shares. (Nasdaq: SFCC)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.